Occudo Quantitative Strategies LP Kinnate Biopharma Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$2.24 - $2.66 $109,509 - $130,042
-48,888 Reduced 70.03%
20,925 $55,000
Q4 2023

Feb 14, 2024
BUY
$1.07 - $2.5 $74,699 - $174,532
69,813 New
69,813 $165,000
Q2 2023

Aug 14, 2023
BUY
$2.33 - $6.84 $35,963 - $105,575
15,435 New
15,435 $46,000

Others Institutions Holding KNTE

# of Institutions
2
Shares Held
292K
Call Options Held
0
Put Options Held
0
View Full List

About Kinnate Biopharma Inc.

KNTE Quotes by TradingView
  • Ticker KNTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,145,600
  • Description
  • Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...
More about KNTE
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email